Inovio Pharmaceuticals, Inc. (INO)
USD 1.78
(-9.18%)
USD 1.78
(-9.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -124.36 Million | -216.21 Million | -215.7 Million | -177.97 Million | -97.85 Million | -73.55 Million |
| Net Income | -135.11 Million | -279.81 Million | -303.65 Million | -167.47 Million | -120.55 Million | -96.96 Million |
| Depreciation & Amortization | 3.5 Million | 5.49 Million | 4.73 Million | 4.62 Million | 5.51 Million | 4.99 Million |
| Deferred income taxes | -32.04 Thousand | 4.02 Million | 5.67 Million | 37.92 Million | -260.81 Thousand | 3.41 Million |
| Stock-based compensation | 11.07 Million | 22.55 Million | 26.33 Million | 15.64 Million | 10.9 Million | 10.65 Million |
| Change in working capital | -10.25 Million | 19.83 Million | 50.35 Million | -71.07 Million | -3.54 Million | 4.7 Million |
| Other non-cash items | 6.46 Million | 11.68 Million | 858.64 Thousand | 2.36 Million | 10.08 Million | -360.79 Thousand |
| Investing Cash Flow | 87.35 Million | 109.58 Million | -175.34 Million | -58.79 Million | -9.04 Million | 42.41 Million |
| Investments in PPE | -320.89 Thousand | -969.15 Thousand | -1.23 Million | -1.52 Million | -987.92 Thousand | -2.08 Million |
| Acquisitions | 6.21 Million | -1.99 Million | 1435.82 Billion | 38.72 Million | 987.92 Billion | 2779.49 Billion |
| Investment purchases | -203.47 Million | -248.52 Million | -348.95 Million | -156.21 Million | -100.95 Million | -88.15 Million |
| Sales/Maturities of investments | 284.93 Million | 361.08 Million | 174.83 Million | 62.99 Million | 92.89 Million | 132.65 Million |
| Other Investing Activities | 1.09 Billion | 110.55 Million | -1435.82 Billion | -2.77 Million | -987.92 Billion | -2779.49 Billion |
| Financing Cash Flow | 4.99 Million | 81.84 Million | 211.49 Million | 465.27 Million | 105.39 Million | 31.03 Million |
| Debt repayment | - | - | - | -171.62 Thousand | -94.12 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.39 Million | -4.61 Million | -4.02 Million | -892.92 Thousand | -611.61 Thousand |
| Common Stock Issuance | 5.46 Million | 82.95 Million | 209.44 Million | 454.48 Million | 9.08 Million | 29.22 Million |
| Other Financing Activities | -466.64 Thousand | 283.02 Thousand | 6.66 Million | 18.84 Million | 284.56 Million | 1.8 Million |
| Accounts receivables | 9.33 Million | -3.7 Million | 11.03 Million | -17.01 Million | 2.02 Million | 2.43 Million |
| Accounts payables | -45.98 Million | 32.6 Million | 26.14 Million | 3.25 Million | -4.58 Million | 601.25 Thousand |
| Inventory | - | - | 15.54 Million | -55.15 Million | 935.79 Thousand | -963.92 Thousand |
| Other working capital | 26.39 Million | -9.06 Million | -2.36 Million | -2.15 Million | -1.91 Million | 2.63 Million |
| Cash at beginning of period | 46.32 Million | 71.14 Million | 250.72 Million | 22.19 Million | 23.69 Million | 23.78 Million |
| Cash at end of period | 14.31 Million | 46.32 Million | 71.14 Million | 250.72 Million | 22.19 Million | 23.69 Million |
| Capital Expenditure | -320.89 Thousand | -969.15 Thousand | -1.23 Million | -1.52 Million | -987.92 Thousand | -2.08 Million |
| Effect of forex changes on cash | -3920.00 | -25.55 Thousand | -30.13 Thousand | 27.2 Thousand | - | - |
| Net cash flow / Change in cash | -32.01 Million | -24.81 Million | -179.58 Million | 228.53 Million | -1.49 Million | -92.94 Thousand |
| Free Cash Flow | -124.68 Million | -217.18 Million | -216.93 Million | -179.49 Million | -98.83 Million | -75.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.23 Million | -30.46 Million | -25 Million | -135.11 Million | -40.64 Million | -35.53 Million |
| Depreciation & Amortization | 828.62 Thousand | 759.73 Thousand | 175.22 Thousand | 3.5 Million | 1.03 Million | 1.14 Million |
| Deferred income taxes | - | - | -32.04 Thousand | -32.04 Thousand | -30.49 Million | 1.08 Million |
| Stock-based compensation | 1.51 Million | 2.52 Million | 2.26 Million | 11.07 Million | 2.07 Million | 2.91 Million |
| Change in working capital | 1.77 Million | -851.25 Thousand | -2.11 Million | -10.25 Million | -7.38 Million | -2.24 Million |
| Other non-cash items | 1.5 Million | 6.62 Million | -1.57 Million | 6.46 Million | 36.84 Million | 313.48 Thousand |
| Investing Cash Flow | 9.96 Million | 45.38 Million | 19.94 Million | 87.35 Million | -5.49 Million | 53.9 Million |
| Investments in PPE | -452.25 Thousand | -35.57 Thousand | 320.89 Thousand | -320.89 Thousand | - | -23.91 Thousand |
| Acquisitions | - | - | 148.26 Thousand | 6.21 Million | - | -53.93 Million |
| Investment purchases | -19.6 Million | -9.75 Million | -29.22 Million | -203.47 Million | -67.5 Million | -26.31 Million |
| Sales/Maturities of investments | 30.02 Million | 55.16 Million | 49.01 Million | 284.93 Million | 62.01 Million | 80.24 Million |
| Other Investing Activities | - | -726.74 Million | 1.03 Billion | 1.09 Billion | - | 53.93 Million |
| Financing Cash Flow | 33.03 Million | -11.36 Million | 1.83 Million | 4.99 Million | 698.63 Thousand | 2.88 Million |
| Debt repayment | - | -16.41 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 456.99 Thousand | - | - | -32.29 Thousand |
| Common Stock Issuance | 33.27 Million | 5.22 Million | 1.83 Million | 5.46 Million | 708.28 Thousand | 2.91 Million |
| Other Financing Activities | -240.12 Thousand | -174.24 Thousand | 13.54 Billion | -466.64 Thousand | -9650.00 | -32.29 Thousand |
| Accounts receivables | 777.41 Thousand | -145.85 Thousand | -261.03 Thousand | 9.33 Million | 2.97 Million | -81.12 Thousand |
| Accounts payables | 798.19 Thousand | -3.16 Million | 4.65 Million | -45.98 Million | -6.68 Million | -3.21 Million |
| Inventory | - | - | 1.15 Million | - | -2.92 Million | 1.76 Million |
| Other working capital | 201.19 Thousand | 2.45 Million | -6.5 Million | 26.39 Million | -741.1 Thousand | -712.37 Thousand |
| Cash at beginning of period | 19.6 Million | 14.31 Million | 18.8 Million | 46.32 Million | 52.71 Million | 28.23 Million |
| Cash at end of period | 34.39 Million | 19.6 Million | 14.31 Million | 14.31 Million | -33.92 Million | 52.71 Million |
| Capital Expenditure | -452.25 Thousand | -35.57 Thousand | 320.89 Thousand | -320.89 Thousand | - | -23.91 Thousand |
| Effect of forex changes on cash | - | 32.4 Thousand | 483.00 | -3920.00 | -2109.00 | -376.00 |
| Net cash flow / Change in cash | 14.79 Million | 5.29 Million | -4.49 Million | -32.01 Million | -86.63 Million | 24.47 Million |
| Free Cash Flow | -28.66 Million | -28.79 Million | -25.95 Million | -124.68 Million | -36.84 Million | -32.33 Million |
WMELF
INBI
NEXE
CEEJAY
JSHL
PLUS